These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37990267)

  • 1. The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer.
    McFadden M; Singh SK; Kinnel B; Varambally S; Singh R
    J Ovarian Res; 2023 Nov; 16(1):220. PubMed ID: 37990267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer.
    Singh SK; Lillard JW; Singh R
    Cancer Lett; 2018 Jul; 427():49-62. PubMed ID: 29678549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
    Tong L; Chen W; Wu J; Li H
    Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
    Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
    Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo.
    Yao S; Li L; Su XT; Wang K; Lu ZJ; Yuan CZ; Feng JB; Yan S; Kong BH; Song K
    J Exp Clin Cancer Res; 2018 Feb; 37(1):29. PubMed ID: 29478415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
    Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
    Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
    Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocyte‑rich microenvironment promotes chemoresistance via upregulation of peroxisome proliferator‑activated receptor gamma/ABCG2 in epithelial ovarian cancer.
    Chen S; Liu Z; Wu H; Wang B; Ouyang Y; Liu J; Zheng X; Zhang H; Li X; Feng X; Li Y; Shen Y; Zhang H; Xiao B; Yu C; Deng W
    Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38426604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery.
    Wu T; Gong Y; Li Z; Li Y; Xiong X
    Curr Drug Deliv; 2021; 18(10):1505-1514. PubMed ID: 33845742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ONC201 induces the unfolded protein response (UPR) in high- and low-grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity.
    Rumman M; Buck S; Polin L; Dzinic S; Boerner J; Winer IS
    Cancer Med; 2021 May; 10(10):3373-3387. PubMed ID: 33932119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming drug-resistance in lung cancer cells by paclitaxel loaded galactoxyloglucan nanoparticles.
    Reshma PL; Unnikrishnan BS; Preethi GU; Syama HP; Archana MG; Remya K; Shiji R; Sreekutty J; Sreelekha TT
    Int J Biol Macromol; 2019 Sep; 136():266-274. PubMed ID: 31201909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CD44-positive ovarian cancers via engineered paclitaxel prodrug nanoparticles for enhanced chemotherapeutic efficacy.
    Sun X; Zhao R; Zhao E; Wang Q; Lian W; Xiong J
    Biomed Pharmacother; 2022 Oct; 154():113655. PubMed ID: 36942600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
    Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
    Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin.
    Kobayashi Y; Seino K; Hosonuma S; Ohara T; Itamochi H; Isonishi S; Kita T; Wada H; Kojo S; Kiguchi K
    Gynecol Oncol; 2011 May; 121(2):390-4. PubMed ID: 21272926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells.
    Dasari VR; Carey DJ; Gogoi R
    BMC Cancer; 2020 Apr; 20(1):273. PubMed ID: 32245422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway.
    Wang X; Xiong T; Cui M; Li N; Li Q; Zhu L; Duan S; Wang Y; Guo Y
    J Nanobiotechnology; 2021 Dec; 19(1):444. PubMed ID: 34949180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.
    Zhao MD; Li JQ; Chen FY; Dong W; Wen LJ; Fei WD; Zhang X; Yang PL; Zhang XM; Zheng CH
    Int J Nanomedicine; 2019; 14():9453-9467. PubMed ID: 31819443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.